{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13201",
      "entity_text" : "ECM",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P03973",
      "entity_text" : "ALP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Levamisole, a well established inhibitor of ALP, inhibited ATDC5 ECM mineralisation at Day 15 of culture at concentrations in excess of 300 muM (P < 0.001) (XREF_FIG) with no apparent alterations in the morphology of the ATDC5 cells (XREF_FIG).",
  "reading_complete" : "2020-08-03T17:36:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:35:58Z",
  "trigger" : "inhibited",
  "evidence" : [ "ALP, inhibited ATDC5 ECM" ],
  "pmc_id" : "3573767",
  "score" : 0
}